Economic evaluations of interventions to prevent healthcare-associated infections – literature review
Each year around 3.2 million patients are infected with healthcare-associated infections following exposure in healthcare facilities across the European Union and a total of 37 000 of them die as a direct consequence. Healthcare-associated infections are therefore of considerable concern to patients, healthcare professionals and policy-makers alike.
The aim of this review is to assist decision-makers by identifying and summarising existing economic evaluations and cost-effectiveness analyses associated with the control and/or prevention of healthcare-associated infections and to establish general assumptions which would be desirable for a common framework to enable future cost-effectiveness analyses in European hospital settings.
ECDC Evidence Brief: Pre-exposure prophylaxis for HIV prevention in Europe and Central Asia
28 Nov 2019 - This evidence brief summarises key issues and priorities for action in Europe and Central Asia on PrEP. It is largely based on data collected in 2018 and 2019 by the European Centre for Disease Prevention and Control (ECDC) to monitor implementation of the 2004 Dublin Declaration. The monitoring questionnaire was disseminated to the 53 countries that are part of the WHO European Region, plus Kosovo and Liechtenstein via an online survey.
Developing a national strategy for the prevention and control of sexually transmitted infections
4 Sep 2019 - This report outlines suggested steps to develop, implement and coordinate a national STI strategy and action plan. It includes approaches to ensure the necessary stakeholder engagement for such strategies to succeed.
Laboratory manual for carbapenem and colistin resistance detection and characterisation for the survey of carbapenem- and/or colistin-resistant Enterobacteriaceae
18 Feb 2019 - This protocol is based partly on the laboratory manual developed for the European survey of carbapenemase-producing Enterobacteriaceae (EuSCAPE)